Announcement under Regulation 30 (LODR)-Allotment
Filed with BSE · · 1 page · English
Summary by 6ix AI
Vivo Bio Tech Ltd. has announced the allotment of equity shares following the conversion of warrants issued on a preferential basis. This allotment increases the company's issued and subscribed share capital significantly.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Vivo Bio Tech
- Vivo Bio Tech Ltd. Press Release Jan 05 2026
- Receipt Of Certificate Of GLP Compliance From National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA), Department Of Science And Technology, Government Of India
- Vivo Bio Tech Ltd. Press Release Dec 27 2025
- Closure of Trading Window
- Vivo Bio Tech Ltd. Press Release Dec 08 2025
Later from Vivo Bio Tech
- Subscription To Convertible Equity Warrants Of M/S. Virinchi Limited Issued On Preferential Basis
- Vivo Bio Tech Ltd. Press Release Jan 08 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Vivo Bio Tech Ltd. Press Release Jan 09 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Vivo Bio Tech into a list and get an email when it puts out news.
Follow Vivo Bio Tech